FirstWord belongs to a business group that forms one of the world’s largest healthcare knowledge networks. By tapping into its rich resources, FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date and actionable intelligence reports that deliver information vital for competitive advantage.

Page

COPD: KOL Insight

By FirstWord Dossier | Healthcare | Apr 2018 | Page 0

Established brands, generics, biologics and new MOAs fight for supremacy in the COPD treatment landscape Established treatments are coming under pressure from generics, new combinations, biologics and new MOAs as the....

USD 8495 View Report

Ovarian Cancer: KOL Insight

By FirstWord Dossier | Healthcare | Apr 2018 | Page 0

PARP inhibitors are firmly entrenched in the treatment algorithm for ovarian cancer, and their role continues to diversify.....

USD 8495 View Report

Medical Affairs in Emerging Markets

By FirstWord Dossier | Healthcare | Apr 2018 | Page 0

Medical affairs capability be enhanced to unlock the Brazilian, Russian, Indian and Chinese pharma markets.....

USD 2495 View Report

Market Access Impact: Renal Cell Carcinoma (EU5) 2018

By FirstWord Dossier | Healthcare | Apr 2018 | Page 0

Renal cell Carcinoma is termed as a kidney cancer originating in the lining of the proximal convoluted tubule of the kidney.....

USD 5345 View Report

Market Access Impact: Renal Cell Carcinoma (US) 2018

By FirstWord Dossier | Healthcare | Apr 2018 | Page 0

Market barriers only affect 8 percent of RCC prescriptions in the US. Is your brand losing out Despite market barriers only affecting 8 percent of all renal cell carcinoma (RCC)....

USD 5345 View Report